Curhan et al1 report an increased risk of hypertension with use of NSAIDs in younger women based on an analysis of data collected from participants in the Nurses' Health Study II. Our experience in a recently completed double-blind randomized controlled trial of NSAID therapy for Alzheimer disease (unpublished data, 2003) provides evidence of risk of hypertension in older individuals.
In the trial, 351 individuals (mean age, 74 years; 53% women) with probable Alzheimer disease were randomly assigned to receive rofecoxib, 25 mg by mouth daily; naproxen sodium, 220 mg by mouth twice daily; or placebo for 1 year. Enrollment criteria required that subjects be medically stable. A history of hypertension was recorded for 115 subjects (33%); these subjects were balanced across the treatment groups. Mean ± SD systolic blood pressure at study entry was 134 ± 16 mm Hg and mean ± SD diastolic blood pressure was 75 ± 10 mm Hg, with no difference across treatment groups. Study visits were conducted at 1, 3, 6, 9, and 12 months after enrollment, with interval history, physical examination, and laboratory studies obtained at each visit. Any significant change in symptoms, physical examination findings, or laboratory values noted during or between study visits was captured as an adverse event.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 6
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
Users' Guides to the Medical Literature
Example 1: Diabetes and Target Blood Pressure
All results at
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.